Unichem Laboratories was up 9.6% after the company received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredients (APIs) facility at Roha. The company received EIR on May 13 for the inspection conducted by the USFDA in late February 2020. The stock has jumped sharply from its recent lows of Rs.75. Unichem functions in therapeutic areas like gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infective and pain management.